Associate Director, Drug Development Portfolio - Princeton, United States - Bristol-Myers Squibb

Bristol-Myers Squibb

Verified Company

Princeton, United States

3 weeks ago

Posted by:

Mark Lane

beBee recruiter

Description

Working with Us
Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.

From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity.

Take your career farther than you thought possible.

Position Summary

The Associate Director, Portfolio Management Insights, Portfolio & Strategic Operations (P&SO), drives portfolio management insights development and delivery to the Global Program Teams (GPTs), Therapeutics Areas (TAs) leaders, Hematology Oncology Cell Therapy (HOCT)/Immunology Cardiovascular Neuroscience (ICN) leadership, crucial for strategic decision-making within the drug development portfolio.

Established in October 2023, this is a new capability at BMS with the vision to become a Drug Development Operational Portfolio Management Insights center, working across the enterprise, including P&SO leads, Business Insights & Analytics (BI&A), Commercial Portfolio Strategy, P&SO Resource management & planning, R&D Finance, and other enterprise functions.

Key Responsibilities

Provides 'fit-for-purpose' portfolio insights to GPT, HOCT & ICN leadership, and TA leadership to enable proactive risk management and cross-functional resource optimization, build awareness and visibility into corporate pipeline goals, priority pipeline execution, and portfolio spend & resource management, in collaboration with P&SO Leads.

Drives development of insights to amplify visibility into critical risks at the GPT, TA, and portfolio levels, informing discussions & decisions by key stakeholders
GPTs, TAs, HOCT/ ICN leadership
Supports evolution of and delivers insights for the portfolio spend and resource calibration analyses across Drug Development organization, in close partnership with R&D Finance and P&SO Resource management & planning.

Partners with Commercial Portfolio Strategy & BI&A to bring integrated analytics to key DD stakeholders, enabling real-time portfolio prioritization at the governance forums informed by operational insights, risk management at the key inflection points in drug development pipeline.

Develops and delivers clear and concise presentations of portfolio insights.

Supports DD portfolio management:

proactively identifies, and escalates operational execution risks that require TA, ICN/HOCT leadership, and Drug Development leadership team (DDLT) actions.

Supports continuous evolution of pipeline reporting to DDLT and BMS leadership

Qualifications & Experience
6+ years of professional experience in the life sciences or biopharmaceutical industry

Expertise in biopharmaceutical Data Science and Statistical analysis preferred.

Degree in Life Sciences or Business Management, and/or advanced degree in related discipline preferred (e.g., PhD, MS, MBA).

Business operations experience and familiarity with divisional management. Expertise in R&D functions (e.g., Clinical Operations, CMC, Regulatory, Project management, Commercial) preferred.

Demonstrated understanding of drug development, portfolio prioritization, strategy, and execution.

Demonstrated strength in partnering across R&D and with business leaders to assess critical needs and operational pipeline performance.

Comfort in an agile work environment and capable of bringing structure to vaguely defined problems while using creative yet pragmatic problem-solving approaches.

Strong communication and interpersonal skills, with the ability to interface with a broad range of internal and external stakeholders at all levels of the organization.

Proactive, organized, and promoter of diversity and inclusivity

Highly effective verbal and written communication skills; strong change & stakeholder management skills.

Ability to build relationships and influence, and drive organizational engagement across functions and sites.

LI-Hybrid

Uniquely Interesting Work, Life-changing Careers

On-site Protocol
BMS has a diverse occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based and remote-by-design jobs.

The occupancy type that you are assigned is determined by the nature and responsibilities of your role:

Site-essential roles require 100% of shifts onsite at your assigned facility. Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility.

For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a positive Company culture.

For field-based and remote-by-design roles the ability t